Spain's Rovi to make ingredients for Moderna's COVID-19 vaccine

MADRID - Spanish pharmaceuticals company Rovi announced on Monday that it will start making the active ingredients for Moderna's COVID-19 vaccine.

Rovi will have the capacity to supply the active agents for up to 100 million vaccine doses a year at its plant in Granada via a new production line. This would be the first European drug ingredients production site for Moderna outside of Switzerland, where Lonza has one large commercial production line now manufacturing drug substances and another two commercial lines nearing completion.